Human papillomaviruses prevalence and genital co-infections in HIV-seropositive women in Ouagadougou (Burkina Faso)

Pakistan Journal of Biological Sciences

Volumn 13, Issue 19, 2010, Pages 951-955

  Sagna, T ^a,b   Djigma, F ^a,b   Zeba, M ^a,b   Bisseye, C ^a,b   Karou, S D ^a,c   Ouermi, D ^a,b   Pietra, V ^a   Gnoula, C ^a,b   Sanogo, K ^a   Nikiema, J B ^a,b   Simpore, J ^a,b  

^a Biomolecular Research Center Pietro Annigoni   (Burkina Faso)

^b UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

^c UNIVERSITY OF LOMÉ   (Togo)

Author keywords

Burkina Faso; HIV; Human papillomavirus; Mycoplasma; Women

Indexed keywords

CANDIDA ALBICANS; ESCHERICHIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 18; MYCOPLASMA; PAPILLOMAVIRIDAE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; TREPONEMA PALLIDUM;

EID: 77957550501     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2010.951.955     Document Type: Article

References (28)

1. Anukam, K.C. and G. Reid, 2007. Organisms associated with bacterial vaginosis in Nigerian women as determined by PCR-DGGE and 16S rRNA gene sequence. Afr. Health Sci., 7: 68-72.
2. Bebear, C. and CM. Bebear, 2007. Infections humaines a mycoplasmes. Rev. Francophone Lab., 391: 63-69.
3. Cutts, F.T., S. Franceschi, S. Goldie, X. Castellsague and S. De Sanjosex et-al, 2007. Human papillomavirus and HPV vaccines: A review. Bull. World Health Organ., 85: 719-726.
4. Dames, D.N., C. Ragin, A. Griffith-Bowe and P. Gomez and R. Butler, 2009. The prevalence of cervical cytology abnormalities and human Papillomavirus in women infected with the human immunodeficiency virus. Infect. Agent Cancer, 4: 1-8.
5. Faye-Kette, H., G. La-Ruche, L. Ali-Napo, N. Messou and I. Viho et al., 2000. Genital mycoplasmas among pregnant women in Cote d'lvoire, West Africa: Prevalence and risk factors. Int. J. STD AIDS., 11: 599-602.
6. Firnhaber, C, K. Zungu, S. Levin, P. Michelow and L.J. Montaner et al, 2009. Diverse and high prevalence of human papillomavirus associated with a significant high rate of cervical dysplasia in human immunodeficiency virus-infected women in Johannesburg, South Africa. ActaCytol., 53: 10-17.
7. Goncalves, M.A.G., G. Randi, A. Arslan, L.L. Villa and M.N. Burattini et al., 2008. HPV type infection in different anogenital sites among HIV-positive Brazilian women. Infect. Agents Cancer, 3: 5-5.
8. Heard, I., 1999. Les lesions cervicales liees au Papillomavirus humain chez des femmes seropositives pour le VIH. Contraception Fertilite Sexualite, 27: 681-686.
9. Heard, I., 2005. Lesions ano-genitales liees a l'infection par les papillomavirus humains chez la femme. Medecine et Maladies Infectieuses, 35: 302-305.
10. Irwin, K.L., A.C. Moorman, M.J. O'Sullivan, R. Sperling and M.E. Koestler et al., 2000. Influence of human immunodeficiency virus infection on pelvic inflammatory disease. Obstet Gynecol., 95: 525-534.
11. Judlin, P., 2003. Mycoplasmes genitaux. Gynecologie Obstetrique Fertilite, 31: 954-959.
12. Larsen, C, 1995. Interaction des infections a papillomavirus (PVH) et a VIH sur la survenue de lesions precancereuses du coluterin. Revue Critique de Factualite Scientifique Internationale Sur le VIH et les Virus des Hepatites. 35(1).
13. Louie, K., M.N. Didelot, A. Damay, N. Nagot, P. Mayaud and M. Segondy, 2008. Human papillomavirus (HPV) and associated cancers: Epidemiological human papillomavirus and associated cancers: Epidemiological aspects human papillomavirus and associated cancers: Epidemiological aspects. Revue Francophone des Laboratoires, 405: 27-34.
14. Machet, L., L. Vaillant, O. Acker and P. Armingaud, 2006. Dermatologie en Gynecologie-Obstetrique. Elsevier, Jordan Hill, Oxford, UK.
15. Mamadou, S., K.A. Laouel, S. Rabiou, A. Aboubacar and O. Soumana et al., 2006. Prevalence of the HIV infection and five other sexually-transmitted infections among sex workers inNiamey, Niger. Bull. Soc. Pathol. Exot, 99: 19-22.
16. Meda, N, S. Ledru, M. Fofana, S. Lankoande, G. Soula, A.J. Bazie and J.P. Chiron, 1995. Sexually transmitted diseases and human immunodeficiency virus infection among women with genital infections in Burkina Faso. Int. J. STD AIDS., 6: 273-277.
17. Minkoff, H. L., D. Eisenberger-Matityahu, J. Feldman, R. Burk and L. Clarke, 1999. Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus. Am. J. Obstet. Gynecol., 180: 824-836.
18. Monsonego, J., 2007. Traite des Infections et Pathologies Genitales a Papillomavirus. Springer, Paris.
19. Moradi, A. and M.A. Talat, 2006. Detection of HPV in cancerous and non-cancerous esophageal tissues from turkmen-sahra, Iran. Int. J. Cancer Res., 2: 113-118.
20. Ouermi, D., 2009. Prevalence of opportunistic infections and viral infections in people living with HIV/AIDS saint camille medical center and CERBA/LABIOGENE in Burkina Faso. Ph.D. Thesis, Unique University of Ouagadougou
21. Pyeon, D., S.M. Pearce, S.M. Lank, P. Ahlquist and P.F. Lambert, 2009. Establishment of human
22. papillomavirus infection requires cell cycle progression. PLoS Pathog., 5: 1000318-1000318.
23. Rapelanoro, R.F., P. Lepere, C. Escarguel, C. Pelissier, P. Lamarque and D. Malvy, 1998. Prevalence de rinfection par mycoplasmes urogenitaux chez la femme atteinte par le VIH a Bangui, Republique centrafricaine. Sante, 8: 189-192.
24. Santin, A.D., P.L. Hermonat, A. Ravaggi, M. Chirivainternati and D. Zhan et al., 1999. Induction of human papillomavirus-specific CD41 andCD81 lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- andl8-Positive cervical cancer. J. Virol, 73: 5402-5410.
25. Singh, A., D. Singhal, S. Bhalla and A. Chaudhary, 2009. Papillary cystadenocarcinoma of extrahepatic left bile duct. Trop. Gastroenterol., 30: 228-229.
26. Smits, P.H.M., R. Bakker, E. Jong, J.W. Mulder and P.L. Meenhorst et al., 2005. High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men. J. Clin. Microbiol, 43: 5936-5939.
27. Spano, J.P., A.G. Marcelin and G. Carcelin, 2005. Cancer et infection a papillomavirus humain. Bull. Cancer, 92: 54-64.
28. Spano, J.P., G. Carcelain, C. Katlama and D. Costagliola, 2006. Les nouvelles tumeurs malignes du patient infectE par le VTH: Aspects cliniques et perspectives. Bull. Cancer, 93: 37-42.